Cargando…

Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

[Image: see text] Targeted protein degradation has emerged as a new paradigm to manipulate cellular proteostasis. Proteolysis-targeting chimeras (PROTACs) are bifunctional small molecules that recruit an E3 ligase to a target protein of interest, promoting its ubiquitination and subsequent degradati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotton, Adam D., Nguyen, Duy P., Gramespacher, Josef A., Seiple, Ian B., Wells, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154509/
https://www.ncbi.nlm.nih.gov/pubmed/33395526
http://dx.doi.org/10.1021/jacs.0c10008
_version_ 1783699031199842304
author Cotton, Adam D.
Nguyen, Duy P.
Gramespacher, Josef A.
Seiple, Ian B.
Wells, James A.
author_facet Cotton, Adam D.
Nguyen, Duy P.
Gramespacher, Josef A.
Seiple, Ian B.
Wells, James A.
author_sort Cotton, Adam D.
collection PubMed
description [Image: see text] Targeted protein degradation has emerged as a new paradigm to manipulate cellular proteostasis. Proteolysis-targeting chimeras (PROTACs) are bifunctional small molecules that recruit an E3 ligase to a target protein of interest, promoting its ubiquitination and subsequent degradation. Here, we report the development of antibody-based PROTACs (AbTACs), fully recombinant bispecific antibodies that recruit membrane-bound E3 ligases for the degradation of cell-surface proteins. We show that an AbTAC can induce the lysosomal degradation of programmed death-ligand 1 by recruitment of the membrane-bound E3 ligase RNF43. AbTACs represent a new archetype within the PROTAC field to target cell-surface proteins with fully recombinant biological molecules.
format Online
Article
Text
id pubmed-8154509
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-81545092021-05-27 Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1 Cotton, Adam D. Nguyen, Duy P. Gramespacher, Josef A. Seiple, Ian B. Wells, James A. J Am Chem Soc [Image: see text] Targeted protein degradation has emerged as a new paradigm to manipulate cellular proteostasis. Proteolysis-targeting chimeras (PROTACs) are bifunctional small molecules that recruit an E3 ligase to a target protein of interest, promoting its ubiquitination and subsequent degradation. Here, we report the development of antibody-based PROTACs (AbTACs), fully recombinant bispecific antibodies that recruit membrane-bound E3 ligases for the degradation of cell-surface proteins. We show that an AbTAC can induce the lysosomal degradation of programmed death-ligand 1 by recruitment of the membrane-bound E3 ligase RNF43. AbTACs represent a new archetype within the PROTAC field to target cell-surface proteins with fully recombinant biological molecules. American Chemical Society 2021-01-04 2021-01-20 /pmc/articles/PMC8154509/ /pubmed/33395526 http://dx.doi.org/10.1021/jacs.0c10008 Text en © 2021 American Chemical Society Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Cotton, Adam D.
Nguyen, Duy P.
Gramespacher, Josef A.
Seiple, Ian B.
Wells, James A.
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
title Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
title_full Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
title_fullStr Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
title_full_unstemmed Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
title_short Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
title_sort development of antibody-based protacs for the degradation of the cell-surface immune checkpoint protein pd-l1
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154509/
https://www.ncbi.nlm.nih.gov/pubmed/33395526
http://dx.doi.org/10.1021/jacs.0c10008
work_keys_str_mv AT cottonadamd developmentofantibodybasedprotacsforthedegradationofthecellsurfaceimmunecheckpointproteinpdl1
AT nguyenduyp developmentofantibodybasedprotacsforthedegradationofthecellsurfaceimmunecheckpointproteinpdl1
AT gramespacherjosefa developmentofantibodybasedprotacsforthedegradationofthecellsurfaceimmunecheckpointproteinpdl1
AT seipleianb developmentofantibodybasedprotacsforthedegradationofthecellsurfaceimmunecheckpointproteinpdl1
AT wellsjamesa developmentofantibodybasedprotacsforthedegradationofthecellsurfaceimmunecheckpointproteinpdl1